Iterum Therapeutics Plc (ITRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,379 | -11,400 | -4,891 | -24,774 | -18,192 |
| Depreciation Amortization | 1,249 | 894 | 543 | 2,572 | 1,736 |
| Accounts receivable | -448 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 326 | 938 | 161 | -4,745 | -4,161 |
| Other Working Capital | -1,428 | -437 | -266 | -12,731 | -11,311 |
| Other Operating Activity | 5,422 | 2,194 | 1,393 | 12,908 | 9,414 |
| Operating Cash Flow | $-15,258 | $-7,811 | $-3,060 | $-26,770 | $-22,514 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 18,210 | 17,110 |
| PPE Investments | -14 | -2 | -2 | -2 | -2 |
| Investing Cash Flow | $-14 | $-2 | $-2 | $18,208 | $17,108 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 16,909 | N/A | N/A | N/A | 12,814 |
| Common Stock Issued | N/A | 11,477 | 6,357 | 26,691 | N/A |
| Other Financing Activity | -14,745 | -14,745 | -14,745 | 0 | 0 |
| Financing Cash Flow | $2,164 | $-3,268 | $-8,388 | $26,691 | $12,814 |
| Exchange Rate Effect | -20 | -18 | -23 | -75 | -73 |
| Beginning Cash Position | 24,159 | 24,159 | 24,159 | 6,105 | 6,105 |
| End Cash Position | 11,031 | 13,060 | 12,686 | 24,159 | 13,440 |
| Net Cash Flow | $-13,128 | $-11,099 | $-11,473 | $18,054 | $7,335 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,258 | -7,811 | -3,060 | -26,770 | -22,514 |
| Capital Expenditure | -14 | -2 | -2 | -2 | -2 |
| Free Cash Flow | -15,272 | -7,813 | -3,062 | -26,772 | -22,516 |